Mon Feb 13, 2023 – 5:36 pm EST
(LifeSiteNews) — The commissioner U.S. Food and Drug Administration (FDA) commissioner recently testified that the agency’s Emergency Use Authorizations (EUAs) are “independent” of the COVID-19 emergency and do not expire.
During a congressional hearing discussing “the federal response to COVID-19″ within the House Committee on Energy and Commerce, Dr. Robert Califf indicated that the federal agency will be transitioning EUAs related to COVID treatments and testing devices to standard procedure.
“Our EUAs are independent of the public health emergency, so we can keep them going as long as we need to,” Califf said. “We’ve been preparing the industry since day one to be ready for the transition. We’ll put a Federal Register Notice out about exactly how to make the transition as these products go to routine use and [are] no longer used on an emergency basis.”
The commissioner’s statement came in response to New Jersey Democrat Rep. Frank Pallone’s question about the “planning for the next phase of the federal response of this pandemic.”
[embedded content]
In an opening statement, Califf said that the FDA has “issued EUAs or provided traditional marketing authorizations to over 2,800
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors